(202 days)
Yes
The device description explicitly states "AutoChamber Software is an opportunistic AI-powered quantitative imaging tool" and "The AutoChamber Software uses an AI trained model".
No
The device is described as an "opportunistic AI-powered quantitative imaging tool" that measures and reports cardiac chamber volumes and cardiothoracic ratio from CT scans. Its purpose is to help physicians investigate patients with signs of enlarged heart or chambers, but it is explicitly stated that it is "not intended to rule out the risk of a cardiovascular disease, and the results should not be used for any purpose other than to enable physicians to investigate patients". The device provides information for diagnostic investigation and does not directly provide therapy or treatment.
Yes
The device measures and reports cardiac chamber volumes and cardiothoracic ratio from CT scans to identify enlarged heart, enlarged cardiac chambers, and left ventricular hypertrophy, which are signs of potential cardiovascular conditions, enabling physicians to investigate patients further. This process of identifying signs of a condition for further investigation is a diagnostic step.
Yes
The device description explicitly states "The AutoChamber Software is a software module installed by trained personnel only." and describes its function as processing existing CT scans. There is no mention of accompanying hardware or hardware components being part of the device itself.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze biological specimens: IVDs are designed to examine samples taken from the human body, such as blood, urine, tissue, etc., to provide information about a person's health.
- This device analyzes medical images: The AutoChamber software processes and analyzes medical images (CT scans) to provide quantitative measurements of cardiac structures. It does not interact with or analyze biological specimens.
Therefore, while it is a medical device used in the diagnostic process, it falls under the category of medical imaging software rather than an In Vitro Diagnostic device.
No
The provided text does not contain any explicit statement that the FDA has reviewed and approved or cleared a Predetermined Change Control Plan (PCCP) for this specific device.
Intended Use / Indications for Use
The AutoChamber software is an opportunistic AI-powered quantitative imaging tool that measures and reports cardiac chambers volumes comprising left atrium (LA), left ventricle (LV), right atrium (RA), right ventricle (RV), and left ventricular wall (LVW) from non-contrast chest CT scans including coronary artery calcium (CAC) scans and lung CT scans. AutoChamber is not intended to rule out the risk of a cardiovascular disease, and the results should not be used for any purpose other than to enable physicians to investigate patients that AutoChamber shows signs of enlarged heart (cardiomegaly), enlarged cardiac chambers, and left ventricular hypertrophy (LVH) whose conditions are otherwise missed by human eyes in non-contrast chest CT scans. AutoChamber similarly measures and reports LA, LV, RA, RV, and LVW in contrast-enhanced coronary CT angiography (CCTA) scans. Additionally, AutoChamber measures and reports cardiothoracic ratio (CTR) in both contrast and non-contrast CT scans where the entire thoracic cavity is in the axial field of view. AutoChamber quantitative imaging measurements are adjusted by body surface area (BSA) and are reported both in cubic centimeter volume (cc) and percentiles by gender using reference data from 5830 people who participated in the Multi-Ethnic Study of Atherosclerosis (MESA). AutoChamber should not be ordered as a standalone CT scan but instead should be used as an opportunistic add-on to existing and new CT scans of the chest, such as CAC and lung CT scans, as well as CCTA scans.
Using AutoChamber quantitative imaging measurements and their clinical evaluation, healthcare providers can investigate asymptomatic patients who are unaware of their risk of heart failure, atrial fibrillation, stroke and other life-threatening conditions associated with enlarged cardiac chambers, and LVH that may warrant additional risk-assessment or follow-up. AutoChamber quantitative imaging measurements are to be reviewed by radiologists or other medical professionals and should only be used by healthcare providers in conjunction with clinical evaluation.
Product codes
QIH
Device Description
The AutoChamber Software is an opportunistic AI-powered quantitative imaging tool that provides an estimate of cardiac volume, cardiac chambers volumes and left ventricular (LV) mass from non-contrast chest CT scans as well as contrast-enhanced chest CT scans. In addition to cardiac chambers volume and LV mass, AutoChamber measures and reports cardiothoracic ratio (CTR).
Mentions image processing
Yes
Mentions AI, DNN, or ML
Yes
Input Imaging Modality
CT scan images (DICOM)
Anatomical Site
Heart / Chest
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Healthcare Provider
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Software Verification and Validation testing was completed to demonstrate the safety and effectiveness of the device. Testing demonstrates the AutoChamber Software meets all its functional requirements and performance specifications.
Clinical validation is based upon retrospective analyses of AutoChamber software measurements in existing prospective studies databases were carried out.
- In one study AutoChamber results were compared with measurements previously made by cardiac MRI in 5003 cases who underwent both non-contrast cardiac CT scan and cardiac MRI.
- AutoChamber results were compared in 1433 patients with paired non-contrast and contrast-enhanced cardiac CT scans.
- AutoChamber results were compared in 171 patients who underwent both ECG-gated cardiac CT scan and non-gated full chest lung scan.
- Clinical performance was established based on direct comparison of AutoChamber results with Reference device (K060937) in 131 cases who underwent both measurements.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the FDA logo is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
October 10, 2024
HeartLung Corporation c/o Mark Scott Regulatory Consultant 2450 Holcombe Blvd Houston, Texas 77021
Re: K240786
Trade/Device Name: AutoChamber Regulation Number: 21 CFR 892.2050 Regulation Name: Medical Image Management And Processing System Regulatory Class: Class II Product Code: QIH Dated: March 7, 2024 Received: March 22, 2024
Dear Mark Scott:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrb/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory
2
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Robert Oaks
Robert Ochs, Ph.D. Director OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K240786
Device Name AutoChamber
Indications for Use (Describe)
The AutoChamber software is an opportunistic AI-powered quantitative imaging tool that measures and reports cardiac chambers volumes comprising left atrium (LA), left ventricle (LV), right ventricle (RV), and left ventricular wall (LVW) from non-contrast chest CT scans including coronary artery calcium (CAC) scans and lung CT scans. AutoChamber is not intended to rule out the risk of a cardiovascular disease, and the results should not be used for any purpose other than to enable physicians to investigate patients that AutoChamber shows signs of enlarged heart (cardiomegaly), enlarged cardiac chambers, and left ventricular hypertrophy (LVH) whose conditions are otherwise missed by human eyes in non-contrast CT scans. AutoChamber similarly measures and reports LA, LV, RA, RV, and LVW in contrast-enhanced coronary CT angiography (CCTA) scans. Additionally, AutoChamber measures and reports cardiothoracic ratio (CTR) in both contrast and non-contrast CT scans where the entire thoracic cavity is in the axial field of view. AutoChamber quantitative imaging measurements are adjusted by body surface area (BSA) and are reported both in cubic centimeter volume (cc) and percentiles by gender using reference data from 5830 people who participated in the Multi-Ethnic Study of Atherosclerosis (MESA). AutoChamber should not be ordered as a standalone CT scan but instead should be used as an opportunistic add-on to existing and new CT scans of the chest, such as CAC and lung CT scans, as well as CCTA scans.
Using AutoChamber quantitative imaging measurements and their clinical evaluation, healthcare providers can investigate asymptomatic patients who are unaware of their risk of heart failure, atrial fibrillation, stroke and other life-threatening conditions associated with enlarged heart, enlarged cardiac chambers, and LVH that may warrant additional riskassessment or follow-up. AutoChamber quantitative imaging measurements are to be reviewed by radiologists or other medical professionals and should only be used by healthcare providers in conjunction with clinical evaluation.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| > Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Image /page/4/Picture/0 description: The image is a logo for "HeartLung". The logo is a blue square with rounded corners. Inside the square is a stylized image of a human torso with a red heart in the center and a blue head at the top. Below the heart are three horizontal lines representing the lungs. The text "HeartLung" is in red at the bottom of the image.
510(K) Summary
This summary of 510(k) safety and effectiveness information is submitted in accordance with the requirements of 21 CFR 807.92:
1. Submitter
HeartLung Corporation 1124 W Carson St. The Lundquist Institute, MRL Building, Floor 3 Torrance, CA 90502 Tel: (650) 448-8089 Contact: Dr. Morteza Naghavi Date Prepared: September 20, 2023
2. Device
Subject Device: Automated Cardiac Chambers Volumetry Software Trade Name: AutoChamber Common Name: AutoChamber Classification: Class II, 21 CFR 892.2050
Product Code: QIH 510(k) #: K240786
3. Predicate Device
Manufacturer: Imbio (Minneapolis, MN), LLC Trade Name: Imbio RV/LV Software Predicate 510(k): K203256
4. Reference Device
Manufacturer: Philips Medical Systems, (Cleveland), Inc. Trade Name: Philips Comprehensive Cardiac Analysis (CCA) Plaque Assessment Tool Reference 510(k): K092747
5. Device Description
General Description
The AutoChamber Software is an opportunistic AI-powered quantitative imaging tool that provides an estimate of cardiac volume, cardiac chambers volumes and left ventricular (LV) mass from non-contrast chest CT scans as well as contrast-enhanced chest CT scans. In addition to cardiac chambers volume and LV mass, AutoChamber measures and reports cardiothoracic ratio (CTR).
| AutoChamber™ is a trademark of the HeartLung Corporation. THIS DOCUMENT IS THE PROPERTY OF HEARTLUNG CORPORATION. © HEARTLUNG CORPORATION. ALL RIGHTS RESERVED. | Pg. 005-1 of 6 |
|---|---|
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ---------------- |
5
Image /page/5/Picture/0 description: The image is a logo for HeartLung. The logo features a stylized representation of the human torso, with lungs outlined in blue and a pink heart in the center. The word "HeartLung" is written in red and blue below the image.
Intended Patient Population
Patients who underwent a chest CT scan.
Principles of Ops
AutoChamber Software reads a CT scan (in DICOM format) and extracts scan specific information like acquisition time, pixel size and scanner type. The AutoChamber Software uses an AI trained model to identify cardiac chambers in the field of view and measure the volume of each chamber including left atrium (LA), left ventricle (LV), right atrium (RA), right ventricle (RV), and LV wall (LVW). AutoChamber calculates the volume of each chamber as well as the corresponding total volume of all cardiac chambers and, if the field of view contains the entire width of the thoracic cavity in the axial view, it calculates and reports cardiothoracic ratio (CTR).
AutoChamber calculates the volume of each chamber based upon the volume of each pixel multiplied by the number of pixels in the region of interest per slice, multiplied by the number of slices included in each chamber's segmentation. The total volume per chamber is reported in cubic centimeters (CC). In addition to reporting the measured volume in CC per chamber report shows volumes adjusted by body surface area (BSA) and corresponding percentiles using reference data from 5830 people who participated in the Multi-Ethnic Study of Atherosclerosis (MESA). The default cut-off value for further investigations is the 75th percentile but it is optional and subject to provider's judgement.
AutoChamber does not provide a numerical individualized risk score/prediction or categorial assessment for whether an individual patient will develop cardiovascular disease over a specified period of their percentile(s).
AutoChamber is a post-processing quantitative imaging software that works on existing and new CT scans. The AutoChamber Software is a software module installed by trained personnel only. The AutoChamber Software is executed via a parent software which provides the necessary input and visualizes the output data. The software itself does not offer user controls or access. The user cannot change or edit the segmentation or results of the device. The user must accept or reject the region where the cardiac chamber volume measurement is done. If rejected, the user must retry with a new series of images or conduct an alternate method to measure cardiac chamber volume. The expert's review solely pertains to the region of interest being properly located.
Software passes if the healthcare provider sees the cardiac chamber volumes and left ventricular mass highlighted by AutoChamber are correctly placed on the cardiac region based upon expert knowledge. Software fails if the healthcare provider sees the cardiac chamber volumes and left ventricular mass highlighted by AutoChamber are incorrectly placed outside of the cardiac anatomy. Software fails if the healthcare provider sees that the quality of the CT scan is compromised by image artifacts, motion, or excessive noise.
Conditions of Use:
| AutoChamber™ is a trademark of the HeartLung Corporation. THIS DOCUMENT IS THE
PROPERTY OF HEARTLUNG CORPORATION.
| © HEARTLUNG CORPORATION. ALL RIGHTS RESERVED. | Pg. 005-2 of 6 |
|---|---|
| ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------- |
6
Image /page/6/Picture/0 description: The image is a logo for HeartLung. The logo features a stylized human torso with a heart and lungs. The heart is pink and in the shape of a heart. The lungs are blue and are on either side of the heart. The torso is blue and is outlined in white. The text "HeartLung" is below the torso in red.
The AutoChamber Software is an AI-powered post-processing software module that works on non-contrast and contrast-enhanced chest CT scans.
6. Intended Use
The AutoChamber software is an opportunistic AI-powered quantitative imaging tool that measures and reports cardiac chambers volumes comprising left atrium (LA), left ventricle (LV), right atrium (RA), right ventricle (RV), and left ventricular wall (LVW) from non-contrast chest CT scans including coronary artery calcium (CAC) scans and lung CT scans. AutoChamber is not intended to rule out the risk of a cardiovascular disease, and the results should not be used for any purpose other than to enable physicians to investigate patients that AutoChamber shows signs of enlarged heart (cardiomegaly), enlarged cardiac chambers, and left ventricular hypertrophy (LVH) whose conditions are otherwise missed by human eyes in non-contrast chest CT scans. AutoChamber similarly measures and reports LA, LV, RA, RV, and LVW in contrast-enhanced coronary CT angiography (CCTA) scans. Additionally, AutoChamber measures and reports cardiothoracic ratio (CTR) in both contrast and non-contrast CT scans where the entire thoracic cavity is in the axial field of view. AutoChamber quantitative imaging measurements are adjusted by body surface area (BSA) and are reported both in cubic centimeter volume (cc) and percentiles by gender using reference data from 5830 people who participated in the Multi-Ethnic Study of Atherosclerosis (MESA). AutoChamber should not be ordered as a standalone CT scan but instead should be used as an opportunistic add-on to existing and new CT scans of the chest, such as CAC and lung CT scans, as well as CCTA scans.
Using AutoChamber quantitative imaging measurements and their clinical evaluation, healthcare providers can investigate asymptomatic patients who are unaware of their risk of heart failure, atrial fibrillation, stroke and other life-threatening conditions associated with enlarged cardiac chambers, and LVH that may warrant additional risk-assessment or follow-up. AutoChamber quantitative imaging measurements are to be reviewed by radiologists or other medical professionals and should only be used by healthcare providers in conjunction with clinical evaluation.
Comparison of Technological Characteristics & Intended Use to Predicate Device
The table below provides a summary of the technological characteristics of the AutoChamber Software in comparison to the predicate device. The indications for use for the predicate device are similar to the indications for the use of the AutoChamber Software. There are no major technological differences between the two systems that raise new issues of safety and/or effectiveness. Thus, we submit the FDA should determine AutoChamber Software is substantially equivalent to the predicate and reference devices.
| AutoChamber™ is a trademark of the HeartLung Corporation. THIS DOCUMENT IS THE
PROPERTY OF HEARTLUNG CORPORATION.
| © HEARTLUNG CORPORATION. ALL RIGHTS RESERVED. | Pg. 005-3 of 6 |
|---|---|
| ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------- |
7
Image /page/7/Picture/0 description: The image is a logo for HeartLung. The logo features a stylized human torso in blue, with a pink heart in the chest area and three horizontal lines representing the lungs. The text "HeartLung" is written in red below the torso.
| Feature | Subject Device
AutoChamber Software
K240786 | Predicate Device: Imbio
RV/LV
K203256 | Reference Device: Philips
Comprehensive Cardiac
Analysis (CCA) K092747 |
|----------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|
| Indication for
Use/Intended
Use | Use an artificial
intelligence algorithm to
identify the location
and measure the volume of
cardiac chambers. | Use an artificial intelligence
algorithm to identify the
location and measurements
of the cardiac ventricles. | Analyzing cardiac CT data
and measuring cardiac
chamber sizes and coronary
plaque analysis. |
| Modality | CT scan images (DICOM) | CT scan images (DICOM) | CT scan images (DICOM) |
| Body Part | Heart / Chest | Heart / Chest | Heart |
| Automatic
definition of
ROIs | Yes, Deep Learning | Yes, Deep Learning | Yes, endoluminal and
epiluminal segmentation |
| Device
provides
volume in CC | Yes | Yes | Yes |
| User | Healthcare Provider | Healthcare
Provider | Healthcare Provider |
| Operating
System | Linux | Windows | Windows |
| Retrospective
measurements
from CT
scans. | CT scan images can be
selected and inputted to the
software | CT scan images can be
selected and inputted to the
software | CT scan images can be
selected and inputted to the
software |
| Automation | | | |
| | Software automatically
identifies cardiac chambers,
estimates and reports the
volume of each chamber | Software automatically
identifies cardiac left and
right ventricles and reports
RV/LV ratio | Software automatically
identifies cardiac chambers,
estimates the volumes and
reports RV/LV ratio |
8
Image /page/8/Picture/0 description: The image is a logo for a company called HeartLung. The logo features a stylized human figure with a heart in the chest area and lungs on either side of the heart. The heart is pink, and the lungs are blue. The text "HeartLung" is written in red and blue below the figure.
7. Performance Data
The following performance data were provided in support of the substantial equivalence determination.
Sterilization & Shelf-Life Testing
Not applicable for this software as a medical device.
Biocompatibility Testing
Not applicable for this software as a medical device.
Electrical Safety and Electromagnetic Compatibility (EMC)
Not applicable for this software as a medical device.
Software Verification and Validation Testing
Software Verification and Validation testing was completed to demonstrate the safety and effectiveness of the device. Testing demonstrates the AutoChamber Software meets all its functional requirements and performance specifications.
Mechanical and Acoustic Testing
Not applicable for this software as a medical device.
Animal Study
Animal performance testing was not required to demonstrate safety and effectiveness of the device.
Clinical Studies
Prospective clinical studies were not required to demonstrate the safety and effectiveness of the device. Instead, clinical validation is based upon retrospective analyses of AutoChamber software measurements in existing prospective studies databases were carried out. In one study AutoChamber results were compared with measurements previously made by cardiac MRI in 5003 cases who underwent both non-contrast cardiac CT scan and cardiac MRI. Furthermore, AutoChamber results were compared in 1433 patients with paired non-
AutoChamber™ is a trademark of the HeartLung Corporation. THIS DOCUMENT IS THE Pg. 005-5 of 6 PROPERTY OF HEARTLUNG CORPORATION. © HEARTLUNG CORPORATION. ALL RIGHTS RESERVED.
9
Image /page/9/Picture/0 description: The image is a logo for "HeartLung". The logo features a stylized representation of the human torso, with the lungs and heart prominently displayed. The heart is colored pink, while the rest of the torso and lungs are in shades of blue. The text "HeartLung" is written in a stylized font below the image.
contrast and contrast-enhanced cardiac CT scans. In yet another study, AutoChamber results were compared in 171 patients who underwent both ECG-gated cardiac CT scan and non-gated full chest lung scan. Additionally, clinical performance was established based on direct comparison of AutoChamber results with Reference device (K060937) in 131 cases who underwent both measurements.
8. Conclusions
The body of testing summarized above indicates that the AutoChamber Software performs as intended and supports a determination of substantially equivalence to the predicate device. The testing above demonstrates that the AutoChamber Software is as safe and effective as the predicate device. No new safety or effectiveness issues are raised by the AutoChamber Software.
| | AutoChamber™ is a trademark of the HeartLung Corporation. THIS DOCUMENT IS THE
PROPERTY OF HEARTLUNG CORPORATION.
© HEARTLUNG CORPORATION. ALL RIGHTS RESERVED. | Pg. 005-6 of 6 |
| -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------- |
|---|